A detailed history of Tower Research Capital LLC (Trc) transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,256 shares of HOWL stock, worth $8,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,256
Previous 23,767 77.89%
Holding current value
$8,094
Previous $57,000 80.7%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.71 - $2.95 $31,653 - $54,607
-18,511 Reduced 77.89%
5,256 $11,000
Q2 2024

Aug 13, 2024

BUY
$2.34 - $6.75 $30,958 - $89,302
13,230 Added 125.56%
23,767 $57,000
Q1 2024

May 15, 2024

BUY
$3.92 - $7.91 $41,305 - $83,347
10,537 New
10,537 $68,000
Q3 2023

Nov 14, 2023

SELL
$2.0 - $3.82 $954 - $1,822
-477 Reduced 16.87%
2,350 $5,000
Q2 2023

Aug 14, 2023

BUY
$2.31 - $3.65 $3,009 - $4,755
1,303 Added 85.5%
2,827 $8,000
Q1 2023

May 09, 2023

SELL
$1.98 - $4.3 $11,131 - $24,174
-5,622 Reduced 78.67%
1,524 $4,000
Q4 2022

Feb 10, 2023

BUY
$1.53 - $4.73 $940 - $2,908
615 Added 9.42%
7,146 $15,000
Q3 2022

Nov 10, 2022

BUY
$4.14 - $7.42 $17,338 - $31,074
4,188 Added 178.75%
6,531 $30,000
Q2 2022

Aug 15, 2022

SELL
$3.43 - $5.98 $1,282 - $2,236
-374 Reduced 13.77%
2,343 $10,000
Q1 2022

May 12, 2022

BUY
$3.71 - $12.22 $7,661 - $25,234
2,065 Added 316.72%
2,717 $12,000
Q4 2021

Feb 14, 2022

BUY
$11.48 - $17.65 $2,686 - $4,130
234 Added 55.98%
652 $8,000
Q3 2021

Nov 15, 2021

BUY
$13.89 - $20.31 $5,083 - $7,433
366 Added 703.85%
418 $7,000
Q2 2021

Aug 16, 2021

BUY
$11.6 - $17.44 $603 - $906
52 New
52 $1,000

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $45.5M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.